Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Care Bare Rx vs Dr. Gillis' Wellness Center

Care Bare Rx
Graded #43

Higher grade

vs+8
Dr. Gillis' Wellness Center
Graded #169

Lower grade

The verdict

Care Bare Rx takes it — 75/100 to 67/100.

Care Bare Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oral as well as injectable routes for both molecules plus a brand Ozempic lane, bundled with hair, TRT and sexual health.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCare Bare Rx +4
68
64
Dose & formulationCare Bare Rx +26
94
68
Clinical oversightDr. Gillis' Wellness Center +10
74
84
Labs & monitoringCare Bare Rx +9
62
53
FulfillmentDr. Gillis' Wellness Center +3
78
81
Contract termsCare Bare Rx +35
72
37
Care Bare Rx · left barDr. Gillis' Wellness Center · right bar

The numbers

MetricCare Bare RxDr. Gillis' Wellness Center
WeighScore75/10067/100
GradeCC
Scorecard rank#43#169
SemaglutideFrom $199/mo (shared weight-loss price)$149/mo (starting dose, compounded)
TirzepatideFrom $199/mo (shared weight-loss price)Not disclosed
CoverageMulti-stateAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesYes
Care Bare Rx

Graded #43 · C

Strengths

  • Oral tirzepatide as well as injectable — rare on this board
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where it loses points

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are

Strengths

  • Sublingual ODT tablets offered as needle-free alternative
  • Broad GLP-1 menu: semaglutide, tirzepatide, and retatrutide
  • Transparent pricing: $150 starting dose, plans from $149/mo
  • Led by board-certified physician/surgeon with 25+ years experience
  • No contracts; flexible weekly, bi-weekly, or monthly cadence

Where it loses points

  • Specific dose-tier pricing beyond starting plan not detailed
  • Compounded vs brand not explicitly stated for all meds
  • Smaller clinic vs national telehealth brands
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard